Insider Transactions Reported by 18 Insiders of OptimizeRx Corp

Symbol
OPRX on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

OptimizeRx Corp executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
WILLIAM J. FEBBO CEO, Director $4,608,010 14 Feb 2025
James Paul Lang Director $4,396,513 +$2,443,761 +125% 11 Jun 2025
Stephen L. Silvestro Chief Executive Officer $2,427,059 -$30,375 -1.2% 23 Dec 2025
Edward Stelmakh Chief Finance & Strat Officer $1,681,283 23 Dec 2025
Miriam Paramore President And Cso $1,670,151 02 Dec 2021
Marion K. Odence-Ford Chief Legal & Admin Officer $1,137,962 23 Dec 2025
Theresa Greco Chief Commercial Officer $928,338 23 Dec 2025
Doug Besch Chief Product & Tech Officer $894,030 23 Dec 2025
GUS D. HALAS Director $865,908 05 Jun 2024
Douglas P. Baker Chief Financial Officer $854,136 05 Oct 2021
Ellen O'Connor Vos Director $799,788 11 Jun 2025
Andrew J. D'Silva Chief Business Officer $637,495 19 Dec 2025
GREGORY D. WASSON Director $629,584 11 Jun 2025
Patrick D. Spangler Director $609,238 -$194,489 -24% 28 Aug 2025
Brendan W. Merrell Chief Operating Officer $371,738 19 Dec 2025
CATHY KLEMA Director $238,036 11 Jun 2025
Todd Inman Chief Technology Officer $177,196 01 Mar 2023
Brian Clark McCarthy Chief Revenue Officer $102,003 02 Aug 2024

Recent Insider Transactions by Companies or Individuals for OptimizeRx Corp

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.